Nymox Pharmaceutical Corporation announced effective June 28, 2022, accepted the resignation of Erik Danielsen as Chief Financial Officer of the Company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2299 USD | +55.34% |
|
+155.44% | -61.03% |
1st Jan change | Capi. | |
---|---|---|
-61.03% | 2.15Cr | |
+34.14% | 5.11TCr | |
-6.54% | 3.94TCr | |
+35.48% | 3.85TCr | |
+12.62% | 2.64TCr | |
-12.11% | 2.62TCr | |
-13.43% | 2.1TCr | |
+43.73% | 1.4TCr | |
+31.81% | 1.25TCr | |
-4.54% | 1.16TCr |
- Stock Market
- Equities
- NYMXF Stock
- News Nymox Pharmaceutical Corporation
- Nymox Pharmaceutical Corporation Announces Resignation of Erik Danielsen as Chief Financial Officer